Spravato (esketamine) Treatment at Med Psych Services

1. What is Spravato?

• Spravato is a nasal spray medication containing esketamine, a form of ketamine.

• It's specifically approved by the FDA for treatment-resistant depression (TRD) in adults, and for depressive symptoms in adults with major depressive disorder (MDD) who have acute suicidal ideation or behavior.

• Unlike traditional antidepressants that primarily target serotonin and norepinephrine, Spravato works on the glutamate system in the brain, which can lead to a more rapid antidepressant effect.
   

2. Who is a Candidate for Spravato?

• Individuals diagnosed with treatment-resistant depression who have not responded adequately to at least two different antidepressant medications.

• Adults experiencing major depressive disorder with acute suicidal ideation or behavior.

• Patients who have undergone a thorough evaluation by a qualified healthcare professional at Med Psych Services to determine their suitability for Spravato treatment.

• Patients that are able to attend the required appointments and abide by the post treatment monitoring guidelines.
   

3. The Spravato Treatment Process at Med Psych Services:

• Initial Evaluation: A comprehensive assessment by our experienced clinicians to determine if Spravato is the right treatment option.

• Treatment Sessions: Spravato is administered in a controlled clinical setting at Med Psych Services, under the supervision of our medical staff.

• Administration: The medication is self-administered as a nasal spray.

• Post-Administration Monitoring: Following administration, patients are monitored for at least two hours to observe for potential side effects.

• Treatment Schedule: Treatment typically involves twice-weekly sessions for the first month, followed by weekly or bi-weekly sessions, as determined by your clinician.

• Integration with Therapy: Med Psych Services strongly recommends combining Spravato treatment with ongoing psychotherapy to maximize and sustain the benefits.

4. Potential Benefits:

• Rapid relief of depressive symptoms, often within hours or days.

• Significant improvement in mood and overall well-being for individuals with TRD.

• Reduction in suicidal ideation and behavior.

• Provides a new option for those who have found limited relief from other treatments.
   

5. Potential Side Effects and Safety:

• Common side effects include dissociation, dizziness, nausea, and changes in blood pressure.

• These side effects are typically temporary and resolve within a few hours.

• Due to the potential for dissociation and sedation, patients must be observed by healthcare professionals for at least two hours after administration.

• Patients are required to have a responsible adult drive them home after each treatment session.

• Med Psych Services will thoroughly review all potential risks and benefits with each patient.
   

6. Why Choose Med Psych Services?

• Experienced and compassionate clinicians specializing in mental health care.

• A safe and supportive treatment environment.

• Personalized treatment plans tailored to individual needs.

• Comprehensive care, including medication management and psychotherapy.

• Adherence to strict guidelines for Spravato administration and patient safety.
   

7. How to Get Started:

• Schedule an initial consultation with one of our clinicians to discuss your treatment options.

• Our team will guide you through the process and answer any questions you may have.

• Contact Med Psych Services via phone, or our website to set up an appointment.